These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 1662427)

  • 1. Antibodies to hepatitis C and surrogate markers in blood donors.
    Koerner K; Stampe D; Glück D; Kubanek B
    Vox Sang; 1991; 61(2):138-9. PubMed ID: 1662427
    [No Abstract]   [Full Text] [Related]  

  • 2. U.K. multicentre study on blood donors for surrogate markers of non-A non-B hepatitis. Part I: Alanine transferase and anti-HBc testing.
    Anderson NA; Raafat A; Shwe KH; Barbara J; Contreras M; Fraser ID; Gunson HH; Martlew V; Mijovic V; Goldíe DJ
    Transfus Med; 1992 Dec; 2(4):301-10. PubMed ID: 1285043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to hepatitis C virus in blood donors and polytransfused patients of Macau (southeast China).
    Martins IA; Ling RC; Fai EL; Chai H; do Rosário Vong MA; de Olim GA
    Vox Sang; 1993; 65(3):245-6. PubMed ID: 7504374
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatitis C viremia in German blood donors: serum alanine aminotransferase is not a valid marker for screening.
    Wolff C; Kleesiek K; Petersen N; Beyer J
    Transfusion; 1994 Apr; 34(4):361-2. PubMed ID: 7513910
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-GOR without anti-HCV core is not associated with hepatitis C viremia.
    Bååth L; Widell A
    Vox Sang; 1994; 66(2):151. PubMed ID: 7514327
    [No Abstract]   [Full Text] [Related]  

  • 6. [Anti-HVC and blood donors. Epidemiologic study of anti-HVC antibodies and the relation to indirect markers (ALT, anti-HBc)].
    Janot C
    Rev Fr Transfus Hemobiol; 1990 Oct; 33(5):347-50. PubMed ID: 2177596
    [No Abstract]   [Full Text] [Related]  

  • 7. Epidemiological studies with anti-hepatitis C virus.
    Bove JR
    Hepatology; 1991 Feb; 13(2):387-8. PubMed ID: 1847354
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of posttransfusion hepatitis B and C by screening for antibody to hepatitis C virus and antibody to HBcAg.
    Chung HT; Lee JS; Lok AS
    Hepatology; 1993 Nov; 18(5):1045-9. PubMed ID: 7693569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The correlations of surrogate markers with anti-hepatitis C virus and other disease markers.
    Myhre BA; Jiminez L; Shitabata P; Ukkestad TS
    Ann Clin Lab Sci; 1994; 24(1):76-83. PubMed ID: 7511879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [International status of anti-HCV screening and conclusions].
    Habibi B
    Rev Fr Transfus Hemobiol; 1990 Oct; 33(5):379-82. PubMed ID: 2177603
    [No Abstract]   [Full Text] [Related]  

  • 11. Detection of HIV-1, HBV and HCV antibodies in blood donors from Surat, western India.
    Nandi J; Bhawalkar V; Mody H; Elavia A; Desai PK; Banerjee K
    Vox Sang; 1994; 67(4):406-7. PubMed ID: 7535499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevalence of HBV and HCV infections in plasma donors with recently increased ALT level].
    Li F
    Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Aug; 14(4):217-9. PubMed ID: 7511485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Significance of alanine aminotransferase screening in blood donors for risk reduction of hepatitis B and C transmission by haemotherapy].
    Kusendová K; Gavorník P; Sabaka P; Sviteková K
    Vnitr Lek; 2016 Jan; 62(1):9-16. PubMed ID: 26967232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The detection of antibodies to the hepatitis C virus and to HBsAg in donors with viral hepatitis and cancerous diseases in the Republic of Moldova].
    Kostritsa SS; Kuzin SN; Khukhlovich PA; Shakhgil'dian IV; Doroshenko NV; Blinov VM; Loparen VN; Sukhanova LL; Gol'tsov VA; Drobeniuk ZhA
    Vopr Virusol; 1994; 39(2):93-4. PubMed ID: 8017065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of non-A, non-B hepatitis after screening blood donors for antibodies to hepatitis C virus and surrogate markers.
    Barrera JM; Bruguera M; Ercilla MG; Sánchez-Tapias JM; Gil MP; Costa J; Gelabert A; Rodés J; Castillo R
    Ann Intern Med; 1991 Oct; 115(8):596-600. PubMed ID: 1909848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of HCV RIBA-2 indeterminate results in high-risk individuals: assessment by a new third-generation RIBA assay and PCR.
    García-Samaniego J; Soriano V; Silva E; Enríquez A; Muñoz F; González-Lahoz J; Di Bisceglie A
    Vox Sang; 1994; 66(2):148-9. PubMed ID: 7514325
    [No Abstract]   [Full Text] [Related]  

  • 17. Seroprevalence of hepatitis B and C virus among professional blood donors--a single centre study of 135 donors in Karachi.
    Ahmed A; Shamsi TS; Hafiz S; Hashmi KZ; Zafar MN; Syed S
    J Pak Med Assoc; 1995 Nov; 45(11):309. PubMed ID: 8920617
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevalence of antibodies to hepatitis viruses in blood donors with a clinical history of hepatitis.
    Vranckx R; Muylle L
    Zentralbl Bakteriol; 1992 Apr; 276(4):540-7. PubMed ID: 1319249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of hepatitis C virus: a study of male blood donors in Saudi Arabia.
    Abdelaal M; Rowbottom D; Zawawi T; Scott T; Gilpin C
    Transfusion; 1994 Feb; 34(2):135-7. PubMed ID: 8310483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lessening the risk of transmission of hepatitis C virus by labile blood products: a role for indirect markers?].
    Jullien AM; Courouce AM; Maniez M; Brevière D; Menault M; Finetti P; Girard M
    Rev Fr Transfus Hemobiol; 1990 Oct; 33(5):355-8. PubMed ID: 2177598
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.